Cyclophosphamide treatment used to manipulate the immune response for the production of monoclonal antibodies
Authors:
- William D. MatthewWMWilliam D. Matthew
- Alfred W. SandrockASAlfred W. Sandrock
- 1 June 1987
- journal article
- research article
- Published by Elsevier in Journal of Immunological Methods
- Vol. 100 (1-2) , 73-82
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- A monoclonal antibody that blocks the activity of a neurite regeneration-promoting factor: studies on the binding site and its localization in vivo.Journal of Cell Biology, 1986
- Cyclophosphamide (Cytoxan)Journal of the American Academy of Dermatology, 1984
- Monoclonal antibodies to the acetylcholine receptor by a normally functioning auto-anti-idiotypic mechanismNature, 1983
- Nerve growth activities in rat peripheral nerveBrain Research, 1982
- Identification of a synaptic vesicle-specific membrane protein with a wide distribution in neuronal and neurosecretory tissue.Journal of Cell Biology, 1981
- Nerve growth factors in the rat irisNature, 1980
- Augmentation of delayed-type hypersensitivity by doses of cyclophosphamide which do not affect antibody responses.Journal of Experimental Medicine, 1975
- POTENTIATION OF T-CELL-MEDIATED IMMUNITY BY SELECTIVE SUPPRESSION OF ANTIBODY FORMATION WITH CYCLOPHOSPHAMIDEJournal of Experimental Medicine, 1974
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970
- Drug-induced Immunological ToleranceNature, 1959